Does stress glucose rise (SHR) predict perioperative MACEs in patients undergoing non-cardiac surgery?
Stress glucose rise (SHR) may serve as a useful predictive tool for assessing the risk of perioperative cardiovascular adverse events in patients undergoing noncardiac surgery.
The SHR was related with an increased risk of perioperative MACEs in patients following noncardiac surgery, highlighting its potential as a useful and reliable predictive tool for assessing the risk of perioperative MACEs.
Lin et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: